Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine local versus intrasphincteric injection for pain after hemorrhoidectomy
IRCT20201031049201N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of bupivacaine in hemorrhoid (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Need for postoperative analgesia. Started Nov 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20201031049201N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201031049201N1.